Medicover

Medicover AB (publ) (“Medicover”) publishes the nomination committee’s composition for the annual general meeting in 2024.

The nomination committee, which is appointed in accordance with the principles adopted by the annual general meeting on 27 April 2023, consists of:

• Fredrik Stenmo, representing Celox Holding AB and the Christina af Jochnick family’s total shareholding
• Hans Ramel, NG Invest Beta AB
• Jannis Kitsakis, Fjärde AP-Fonden
• Angelica Hanson, AMF och AMF Fonder

The Board of Medicover AB (publ)

For more information, please visit:medicover.com

Shareholders who wish to submit proposals to the nomination committee for the annual general meeting to be held on 26 April 2024 can do so by e-mail to nominationcommittee@medicover.com or:

Medicover AB

Att: Nomination Committee/General Legal Counsel

Box 5283, 102 46 Stockholm

Sweden

Proposals should be submitted to the nomination committee at latest on 8 March 2024.

For further information, please contact:

Hanna Bjellquist, Head of Investor Relations

+46 703 033 272
hanna.bjellquist@medicover.com

Medicover is a leading international healthcare and diagnostic services company and was founded in 1995. Medicover operates a large number of ambulatory clinics, hospitals, specialty-care facilities, laboratories and blood-drawing points and the largest markets are Poland, Germany, Romania and India. In 2022, Medicover had revenue of €1,510 million and more than 44,700 employees. For more information, go to www.medicover.com